SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-048651
Filing Date
2024-04-26
Accepted
2024-04-26 07:15:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A itrm_defa14a_notice_acce.htm DEFA14A 26398
2 GRAPHIC img181176149_0.jpg GRAPHIC 1154410
3 GRAPHIC img181176149_1.jpg GRAPHIC 952685
  Complete submission text file 0000950170-24-048651.txt   2929510
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38503 | Film No.: 24878587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)